ArticleCase reports in oncology

Major Durable Response of Pembrolizumab in Chemotherapy Refractory Small Cell Bladder Cancer: A Case Report.

Olav Toai Duc Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.